Bio Essence Corporation reported earnings results for the second quarter and six months ended June 30, 2023. For the second quarter, the company reported sales was USD 0.141906 million compared to USD 0.138511 million a year ago. Revenue was USD 0.259574 million compared to USD 0.288136 million a year ago. Net loss was USD 0.284515 million compared to USD 0.164193 million a year ago. Basic loss per share from continuing operations was USD 0.01.
For the six months, sales was USD 0.291666 million compared to USD 0.32009 million a year ago. Revenue was USD 0.600903 million compared to USD 0.59455 million a year ago. Net loss was USD 0.463351 million compared to USD 0.397315 million a year ago. Basic loss per share from continuing operations was USD 0.01 compared to USD 0.01 a year ago.